
May 28, 2020
Experimental Drug Found to Improve Symptoms of Generalized Myasthenia Gravis
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.